Journal Articles
Featured Topics
Lead story
Other featured articles
-
Factors Associated with Unintended Pregnancy, Contraceptive Risk-Taking, and Interest in Pharmacist-Provided Birth Control
Although overall rates of unplanned pregnancies have declined, significant racial and geographic disparities persist. At the same time, there are new opportunities to improve access to contraception. This study identifies contributors to the high rate of unplanned pregnancies in a rural farming community in California and assesses interest in pharmacist-prescribed contraception.
Posted in -
Now Is the Time for Transparency in Value-Based Healthcare Decision Modeling
Peer-reviewed journals could make a key contribution to improving scientific rigor and real-world healthcare decision-maker acceptability by requiring that VHDM models, source code, and data used in published articles be made freely available to interested readers.
Posted in -
How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma
Innovations that extend life can generate option value and cost of experiencing future technologies. Schaeffer postdoc Meng Li developed generalizable approaches to estimating option value in cost-effectiveness analysis.
Posted in -
Material–Psychosocial–Behavioral Aspects of Financial Hardship: A Conceptual Model for Cancer Prevention
RCMAR Scientist Reginald Tucker-Seeley presents a model to consistently measure financial hardship to better inform cancer prevention research identify connections between socioeconomic circumstances and cancer risk-related behaviors and cancer screening among older adults.
Posted in
ADDITIONAL JOURNAL ARTICLES
-
State and Federal Policy Solutions to Rising Prescription Drug Prices in the U.S.
States are addressing drug pricing issues through one of two domains. First, states are targeting drug pricing directly for both branded and generic products. Second, states are exploring topics in drug price transparency. Padula outlines state and federal policy options targeted prescription drugs that are currently being pursued.
Categorized in -
Geographic Variation in the Delivery of High-Value Inpatient Care
Hospitals in Miami produced 13 percent fewer high-quality hospital stays than the U.S. average, while hospitals in Everett, Washington, a city 25 miles north of Seattle, perform over 20 percent better than average on value.
Categorized in -
Civil Monetary Penalties Resulting From Violations of the Emergency Medical Treatment and Labor Act (EMTALA) Involving Psychiatric Emergencies, 2002 to 2018
Nearly one in five civil monetary penalty settlements related to EMTALA violations involved psychiatric emergencies.
Categorized in -
Impact of Oncology Drug Shortages on Chemotherapy Treatment
Jacobson and Alpert studied more than 2.4 million monthly claims for chemotherapy treatment and found little impact on outpatient chemotherapy treatment for the majority of oncology drugs identified as experiencing shortages between 2004 and 2011.
Categorized in -
Measuring The Lifetime Costs Of Serious Mental Illness And The Mitigating Effects Of Educational Attainment
Using a dynamic microsimulation model to estimate the lifetime burden of serious mental illness for those diagnosed by age twenty-five, the researchers estimated that the per-patient lifetime burden of SMI is $1.85 million.
Categorized in -
Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program
In this study of patients 65 years and older, short-term postdischarge mortality did not appear to increase for black patients under the HRRP, suggesting that certain value-based payment policies can be implemented without harming black populations. However, mortality seemed to increase for white patients with HF and this situation warrants investigation.
Categorized in